Why Allkem, IGO, Northern Star, and Race Oncology shares are racing higher

These ASX shares are ending the week strongly.

| More on:
Rising share price chart.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positive note. At the time of writing, the benchmark index is up 0.4% to 7,351.1 points.

Four ASX shares that are climbing more than most today are listed below. Here's why they are racing higher:

Allkem Ltd (ASX: AKE)

The Allkem share price is up 4.5% to $11.55. This is despite there being no news out of the lithium miner. However, it is worth noting that a number of lithium shares are ending the week strongly. In addition, Goldman Sachs named Allkem as one of two ASX lithium shares to buy earlier this week.

IGO Ltd (ASX: IGO)

The IGO share price is up 5% to $13.38. This morning, this green metals miner revealed that it has secured land to build its proposed Integrated Battery Material Facility (IBM Facility). The project's development will see a downstream nickel refinery integrated with a plant producing high-value nickel dominant precursor cathode active material.

Northern Star Resources Ltd (ASX: NST)

The Northern Star share price is up 4% to $14.36. Investors have been buying Northern Star and other gold miners today after the price of the precious metal rose to a new one-year high. This has seen the S&P/ASX All Ordinaries Gold index rise a sizeable 2.9% this afternoon.

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price is up 6.5% to $1.87. This has been driven by the release of a detailed commercial assessment of the market potential for its Zantrene product as a cardio-protective agent or dual cardio-protective and anti-cancer agent in breast, endometrial, and ovarian cancers. Management sees scope to generate revenue as high as US$8 billion a year from the product.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A young smiling couple out hiking enjoy a view from the top of the mountains.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors enjoyed a rosy end to the trading week this Friday.

Read more »

A graphic showing a businessman running up a white upwards rising arrow symbolising the soaring Magellan share price today
Share Gainers

How these 3 ASX 200 stocks led the charge higher this week

The three top ASX 200 stocks are up 14% to 34% this week.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Imugene, Neuren, Sigma, and Smartgroup shares are charging higher

These shares are ending the week on a high. But why? Let's find out.

Read more »

A happy girl in a yellow playsuit with a zip gives the thumbs up
BNPL shares

Is this why the Zip share price keeps breaking records?

Zip shareholders have been enjoying a record breaking year. Is this why?

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile, but positive, day for ASX shares this Thursday.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Block, GQG, Neuren, and Sigma shares are racing higher today

These shares are rising on Thursday. But why?

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Brainchip, Cooper Energy, Core Lithium, and Neuren shares are roaring higher today

These shares are having a good time on hump day. But why?

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors endured a rough day of trading this Tuesday.

Read more »